Results 1-7 of 7 (Search time: 0.0 seconds).
|2016||Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors||권영주; 전규연||Article|
|2015||Modified 2,4-diaryl-5H-indeno[1,2-b]pyridines with hydroxyl and chlorine moiety: Synthesis, anticancer activity, and structure-activity relationship study||권영주||Article|
|2017||Novel 2-aryl-4-(4 '-hydroxypheny1)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors||권영주||Article|
|2015||Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines||권영주||Article|
|2016||Recent advances in anticancer chemotherapeutics based upon azepine scaffold||창동신||Review|
|2015||Topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines||권영주||Article|
|2016||Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines||권영주; 전규연||Article|